Clinical Trial Update: A Study of Subcutaneous C.E.R.A. for the Treatment of Anemia in Pre-Dialysis Patients. [Phase 3]

View source ↗

Summary

This document reports the completion and posted results of a Phase 3 trial evaluating subcutaneous C.E.R.A. (methoxy polyethylene glycol-epoetin beta) for treat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2016-11-30